Injective Bitnomial Futures: Can INJ Clear the Path to a Staked ETF? Derivatives for INJ listed in the US have now traded for more than six months, and that milestone matters for the next big
Derivatives for INJ listed in the US have now traded for more than six months, and that milestone matters for the next big step: a staked INJ exchange-traded fund.
The Injective Bitnomial futures went live in April on a federally supervised exchange, giving institutions a familiar way to trade the token.
Here is a plain-language guide to how the contracts work, why six months matters, and what is still not confirmed.
On 15 April 2026,US-regulated INJ futures began trading on Bitnomial Exchange, a designated contract market overseen by the CFTC.
Bitnomial is also a clearinghouse and is owned by Payward, the parent company of Kraken.
Counting from the launch date, the contracts passed the six-month mark in mid-October.
Under the SEC’s generic listing standards, approved in September 2025, a commodity-backed product can list without individual SEC review once its underlying asset has had futures on a CFTC-regulated market for at least six months.
That history is one of several conditions, so meeting it does not guarantee a listing.
The reason these contracts matter: many institutions cannot hold tokens directly because of compliance, custody, and internal risk rules, while a CFTC-overseen contract comes with clearing, margin and counterparty protections already built in.
Milestone
Detail
Contract launch
15 April 2026
Venue
Bitnomial Exchange, CFTC-regulated
Six months reached
Mid-October 2026
Product status
Filed, not yet confirmed as listed
Institutions trade throughBitnomial’s clearing member brokers. Each contract settles in the crypto itself and expires monthly.
Traders can post crypto or US dollars as margin through Bitnomial Clearinghouse, so they can fund positions with assets they already hold instead of selling them first.
Hedge funds, prop desks, and family offices can use them to gain exposure, hedge, or build portfolio strategies.
Retail access was planned through Bitnomial’s Botanical platform, and perpetual contracts and options were announced as the next products.
Availability can change, so traders should confirm current offerings directly with the exchange.
Canary Capitalfiled an S-1 with the SEC in July 2025 for the Canary Staked INJ ETF, proposed to list on Cboe BZX.
BitGo Trust Company is named as custodian and U.S. Bancorp Fund Services as transfer agent, while Cboe filed the matching 19b-4 application the same month.
The ETF would stake its holdings and earn rewards on top of price exposure, a feature that sets it apart from most crypto proposals. A European product from 21Shares, called AINJ, already exists.
The ticker INJC has been referenced for the product, though a listing date has not been confirmed. Nothing here guarantees approval or a launch.
The two products solve different problems, and the difference is easy to miss.
Feature
Futures
Proposed staked ETF
Main user
Institutions and, later, retail traders
US investors with a brokerage account
What you get
Exposure to price moves
Ownership of staked INJ through ETF shares
Settlement
Crypto-settled, monthly
Rewards restaked into the fund’s value
Status
Live
Filed, listing pending
In short, the Injective Bitnomial futures give US institutions a supervised way to trade INJ, while INJC is designed to give investors a regulated way to own it, staked, in the same account they use for other holdings.
Contracts suit hedging and portfolio strategies
The product suits long-term holders who prefer a brokerage account
Neither product removes market risk
The stack of regulated products around the token keeps growing. In August 2026,Injective Institutional Services registered with the SEC as a transfer agent, a step meant to bring regulated and tokenized markets onchain.
The network itself is a Layer 1 built for finance, with an on-chain order book, sub-second finality, and links to Ethereum and Solana.
Validators such as Google Cloud and Binance already signal institutional interest. CME Group lists derivatives for Bitcoin, Ether, Solana, and other top crypto assets, and INJ now joins a small group with CFTC-listed contracts.
A native EVM mainnet arrived in November 2025 to widen compatibility for developers and institutions.
Listed derivatives, institutional-grade validators, and an active ETF filing now sit side by side, which explains why the Injective Bitnomial futures milestone draws attention beyond derivatives traders.
The Injective Bitnomial futures have cleared an important regulatory hurdle, and the staked ETF filing is the next chapter to watch. Still, no listing date, approval, or price effect is confirmed.
Follow official channels, check the exchange for live product details, and remember that this article is not financial advice.
This article is for educational and informational purposes only and is not financial or investment advice. Crypto assets are high risk, their prices can be very volatile, and you can lose some or all of your money. Always do your own research and consider speaking with a licensed financial advisor before making investment decisions.
